Abstract:
A liquid crystal display includes a liquid crystal display panel that is divided into a first display surface and a second display surface including data lines and gate lines, a first data driving circuit configured to drive data lines of the first display surface, a second data driving circuit configured to drive data lines of the second display surface, a gate driving circuit configured to sequentially supply a gate pulse for scanning the first display surface to gate lines of the first display surface and sequentially supply a gate pulse for scanning the second display surface to gate lines of the second display surface, a timing controller configured to divide a unit frame period into a first sub-frame period and a second sub-frame period, a backlight unit configured to provide light to the liquid crystal display panel wherein the backlight unit includes a plurality of light sources, and a light source driving circuit configured to turn off all the plurality of light sources during the first sub-frame period and turn on all the plurality of light sources at a turn-on time within the second sub-frame period.
Abstract:
An electrolyte for the lithium secondary battery having flame retardancy, low negative electrode interfacial resistance, and excellent high temperature properties and life characteristics, and a lithium secondary battery including the same. An electrolyte for lithium secondary battery of the present invention may include a non-aqueous organic solvent, a lithium salt, fluorinated ether or phosphazene, and a resistance-improving additive represented as the following chemical formula (1): RSO2—R1—SO2F [Chemical Formula 1] wherein R1 is a C1-C12 hydrocarbon unsubstituted or substituted with at least one fluorine.
Abstract:
The present invention relates to the use of internal promoters in mammalian expression vectors including plasmid vectors and enhancer-deleted retroviral vectors. The retroviral vectors have improved safety and optimal levels of transgene expression and vector titers.
Abstract:
A unified fuel processing reactor for a solid oxide fuel cell can reform hydrocarbon-based fuel into hydrogen-rich gas, remove a sulfur component, and convert non-converted fuel and a low carbon (C2˜C5) hydrocarbon compound into hydrogen and methane in a single reactor. The reactor comprises a primary-reformer which reforms a hydrocarbon-base fuel and generates hydrogen-rich reformed gas, a desulfurizer which removes a sulfur component from the reformed gas, and a post-reformer which selectively decomposes a low carbon (C2˜C5) hydrocarbon in the desulfurized reformed gas into hydrogen and methane. The primary-reformer, desulfurizer and post-reformer are in the unified reactor and isolated, except for a fluid passage, from each other by internal partition walls. The primary-reformer is disposed at a center portion of the reactor. The post-reformer and the desulfurizer are concentrically disposed outside of the primary-reformer.
Abstract:
In circumstance of a wearable computing system, in order to effectively transfer data between electronic devices using electric property of human body, minimization, low power, and high-speed are required. Human body data communication apparatus and module using broadband signaling technology is provided to perform high-speed peer-to-peer data communication with a signal electrode and low power. The apparatus and module have a direct coupling interface with a single electrode without an antenna and a sensor, and a transmitter transmitting digital signal without modulation, and a receiver recovering a clock and data by detecting a broadband pulse signal.
Abstract:
The present invention relates to the use of internal promoters in mammalian expression vectors including plasmid vectors and enhancer-deleted retroviral vectors. The retroviral vectors have improved safety and optimal levels of transgene expression and vector titers.
Abstract:
The present invention is related to pharmaceutical composition essentially comprising herbal extract of Chaenomelis Fructus, Achyranthis Radix, Acanthopanax, Phlomidis Radix, Gentianae Radix, Clematidis Radix, and additionally comprising herbal extract selected from group consisting of Angelicae Radix, Cnidii Rhizoma, Gastrodiae Rhizoma, Safflower, Cinnamomi Cortex, Job's tear, Aurantii nobilis Pericapium, Ledebouriellae Radix, Lonicera japonica, Akebiae caulis, Caragana chamlagu, Licorice root, Notopterygium incisum, Persicae semen, Eucommia ulmoides, Atractylodes Rhizoma, Torilis japonica according to the need for the prevention and treatment of arthritic diseases and methods of using the above extracts and composition as potent anti-inflammatory and anti-arthritic agents.
Abstract:
The present disclosure relates to an electrolyte for a lithium secondary battery capable of improving safety and reliability of the lithium secondary battery and a lithium secondary battery comprising the electrolyte. The electrolyte for a lithium secondary battery of the present embodiments comprises a non-aqueous organic solvent, a lithium salt, flame retarding materials of fluoroalkyl ether and phosphazene, and a solvent comprising at least one ester.
Abstract:
An analog signal processor (ASP) application-specific integrated circuit (ASIC) is disclosed. The ACIS can be used for remotely monitoring ECG signals of a subject that has reduced power consumption. In one aspect, the ASIC performs the functions of: ECG signal extraction with high resolution using ECG readout channel, feature extraction using a band-power extraction channel, adaptive sampling the ECG signals using an adaptive sampling analog-to-digital converter, and impedance monitoring for signal integrity using an impedance monitoring channel. These functions enable the development of wireless ECG monitoring systems that have significantly lower power consumption but are more efficient that predecessor systems. In one embodiment, the ASP ASIC consumes 30 μW from a 2V supply with compression provided by adaptive sampling providing large reductions in power consumption of a wireless ECG monitoring system of which the ASP ASIC forms a part.
Abstract:
The present invention relates to a use of a crude extract, non-polar solvent soluble extract or purified extract of the hardy kiwifruit for the preparation of therapeutic agent for treating and preventing baldness disorder and seborrheic skin disease in human and mammal, and health care food, food additives, feed additives, cosmetic composition comprising the same. The hardy kiwifruit reduced blood DHT level, promoted the formation of hair root in mouse model experiment, and inhibited the falling out of hair and improved seborrheic skin disease of volunteers such as keratigenous skin, seborrhea etc.